Market closed · After hours · 5:24 PM ET
Last update: Nov 19, 2026, 5:22 PM ET
Insmed Incorporated
▲ 20.9% on Nov 19, 2026

Why Insmed Incorporated (INSM) Stock Rose 20.9% on Nov 19, 2026

Researched by BestStocks Market Desk · Published Nov 19, 2026
Prior close
$119.80
Nov 19, 2026 close
$144.46
Change
+$24.66
+20.58%
Rel. volume
5.2×
14.4M shares

What happened

Material / Earnings+20.9%high confidence

Insmed Incorporated (INSM) moved +20.89% from $119.50 to $144.46 on 2026-11-19 after Bloomberg reported that pharmaceutical giant Sanofi is exploring a potential acquisition of the company. Talks are ongoing with no guarantee of completion, but analysts estimate Insmed could command $170–$210 per share in a buyout, suggesting a 20–50% acquisition premium from the pre-announcement price.

Source: daily_prices:fmp_change_percent
What to watch next

Monitor for updates on Sanofi takeover negotiations and any competing bids; next scheduled earnings announcement is 2027-02-18.

Other developments that session

News

Insmed stock surges on report that Sanofi is considering acquiring the biopharma company.

Source: Barron's

Frequently asked questions

Why did Insmed Incorporated (INSM) stock rise on Nov 19, 2026?

Insmed Incorporated (INSM) moved +20.89% from $119.50 to $144.46 on 2026-11-19 after Bloomberg reported that pharmaceutical giant Sanofi is exploring a potential acquisition of the company. Talks are ongoing with no guarantee of completion, but analysts estimate Insmed could command $170–$210 per share in a buyout, suggesting a 20–50% acquisition premium from the pre-announcement price.

How much did INSM stock rise on Nov 19, 2026?

INSM rose 20.9% during the Nov 19, 2026 trading session.

This is an archived analysis of INSM's Nov 19, 2026 session.
See INSM's latest changes →
Educational research tool — not personalized investment advice. Figures reflect the Nov 19, 2026 session as first analyzed.